IIIV:NASDAQi3 Verticals, Inc. Analysis
Data as of 2026-05-29 - not real-time
Latest Price
Risk Level: High
Executive Summary
i3 Verticals is trading at $20.05, which sits below its 20‑day (20.55) and 50‑day (21.46) simple moving averages, indicating short‑term weakness, yet the MACD histogram (+0.059) and a bullish MACD signal suggest underlying momentum may be turning. The stock’s RSI of 45 is neutral, while volatility is elevated at ~49% over the past 30 days, underscoring a high‑risk price environment. Fundamentals show modest top‑line growth (6.2% YoY revenue increase to $293 M) but profitability remains a concern with a negative net margin (‑2%) and a debt‑to‑equity ratio of 19.5, reflecting heavy leverage. Valuation metrics are stretched – a trailing P/E of 182 versus an industry average of 41 and a DCF‑derived fair value of $3.11 imply the market is pricing in significant growth expectations despite the current earnings gap. Recent earnings releases highlight stronger recurring revenue and a forward EPS outlook of $1.27, supporting a forward P/E of 15.85 and a “strong_buy” analyst consensus with a median target of $28.50, suggesting upside potential if the company can sustain its revenue momentum and improve margins.
Market Outlook
Short Term
< 1 yearKey Factors
- Price below short‑term SMAs indicating bearish bias
- High 30‑day volatility (~49%) raising price risk
- Bullish MACD histogram suggesting possible near‑term rebound
Medium Term
1–3 yearsKey Factors
- Forward P/E of 15.9 aligns with more reasonable valuation
- Recurring revenue strength and FY2026 revenue guidance $221‑$229 M
- Analyst consensus of strong_buy with median target $28.50 (+42% upside)
Long Term
> 3 yearsKey Factors
- Persistent high leverage (debt‑to‑equity 19.5) and negative profit margin
- DCF fair value of $3.11 suggests long‑run valuation pressure
- Technology‑infrastructure sector exposure to budget cycles and regulatory changes
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.